Sangamo BioSciences | Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
Alaunos Therapeutics USD -7.84M 633K 2023-12
Alnylam Pharmaceuticals USD 238.97M 274.33M 2025-09
Alterity Therapeutics Limited AUD -4.74M 3.53M 2024-12
Amgen USD 3.92B 2.35B 2025-09
Bayer EUR -1.16B 735M 2025-09
BioCryst Pharmaceuticals USD -86.95M 73.5M 2024-12
Biogen USD 557.3M 186.7M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Cipla INR 11.69B 6.85B 2025-12
Clal Biotechnology ILS 86.82M 17.9M 2022-12
Compugen USD -6.94M 421K 2025-09
CSL USD 1.4B 1.14B 2025-06
Gilead Sciences USD 3.64B 1.21B 2025-09
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Grifols EUR 66.98M 19.92M 2024-06
Ionis Pharmaceuticals USD -129M 253M 2025-09
J&J USD 4.97B 2.53B 2025-12
Karyopharm Therapeutics USD -30.89M 1.16M 2024-12
Merck USD 6.74B 22M 2025-09
Novartis USD 4.2B 335M 2025-09
Omeros USD -65.12M 21.27M 2024-06
Pfizer USD 3.33B 290M 2025-09
Roche Holding CHF 4.79B 3.01B 2025-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sanofi EUR -1.16B 5.5B 2025-12
Sarepta Therapeutics USD -194.05M 347.69M 2025-09
Tectonic Therapeutic USD -19.04M 25K 2025-09
Ultragenyx Pharmaceutical USD -179.54M 65.54M 2025-09
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09


Sangamo BioSciences Bénéfice Avant Impôts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.